B
Eli Lilly and Company LLY
$746.06 -$9.51-1.26% NYSE
Recommendation
Prev Close
$755.57
Volume
4,523,911
Avg Vol (90D)
3,967,145
Market Cap
$678.30B
Dividend & Yield
$5.40(0.71%)
52-Week Range
$677.09 - $972.53
P/E (TTM)
61.47
EPS (TTM)
$12.29
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
5/6/2025 - MarketBeat
Rep. Bruce Westerman Sells Eli Lilly and Company (NYSE:LLY) Shares
5/14/2025 - MarketBeat
Should I buy the most popular FTSE 100 stock on AJ Bell?
5/14/2025 - The Motley Fool UK
Trump's EO Targets Big Pharma Stocks like Eli Lilly
5/13/2025 - Zacks Investment Research
Eli Lilly and Company (NYSE:LLY) Trading Up 2.8% - Should You Buy?
5/13/2025 - MarketBeat
Best Pharmaceutical Stocks To Keep An Eye On - May 12th
5/13/2025 - MarketBeat
Eli Lilly's (LLY) Weight Loss Drug Outperforms Rival Novo Nordisk in First Head-to-Head Study
5/13/2025 - TipRanks Financial Blog
Top Medical Stocks To Watch Today - May 12th
5/13/2025 - MarketBeat
Tuesday links: inconsistent time horizons
5/13/2025 - Abnormal Returns
PFE vs. LLY: Which Stock Is the Better Value Option?
5/13/2025 - Zacks Investment Research
The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen
5/13/2025 - Zacks Investment Research
Why Lilly (LLY) International Revenue Trends Deserve Your Attention
5/13/2025 - Zacks Investment Research
OMERS ADMINISTRATION Corp Grows Stock Position in Eli Lilly and Company (NYSE:LLY)
5/13/2025 - Ticker Report
RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US
5/13/2025 - Zacks Investment Research
Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared
5/13/2025 - Zacks Investment Research
Leigh Baldwin & CO. LLC Takes Position in Eli Lilly and Company (NYSE:LLY)
5/13/2025 - MarketBeat
NDVR Inc. Has $259,000 Stock Position in Eli Lilly and Company (NYSE:LLY)
5/13/2025 - Ticker Report
Eli Lilly and Company (NYSE:LLY) Shares Sold by Laird Norton Wetherby Wealth Management LLC
5/13/2025 - MarketBeat
Eli Lilly and Company (NYSE:LLY) Shares Acquired by Laraway Financial Advisors Inc
5/13/2025 - MarketBeat
Trump blames 'brutal' Europe for soaring drug costs in bid to curb U.S. prices
5/13/2025 - Fortune
The Seed 40: The best women early-stage investors of 2025
5/13/2025 - Insider
Sangamo Therapeutics Inc (SGMO) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ...
5/13/2025 - GuruFocus
Eli Lilly (LLY): Buy, Sell, or Hold Post Q1 Earnings?
5/13/2025 - StockStory Articles
Eli Lilly and Company (NYSE:LLY) Trading Up 2.8% - Should You Buy?
5/12/2025 - Ticker Report
Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY
4/23/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$49.00B
EBITDA (TTM)
$22.00B
EBIT (TTM)
$20.17B
Net Income (TTM)
$11.11B
Balance Sheet
Total Assets (Q)
$89.39B
Total Debt (Q)
$38.60B
Total Liabilities (Q)
$73.54B
Book Value Per Share (Q)
$16.64
Cash Flow
Cash from Operations (TTM)
$9.32B
Cash from Investing (TTM)
-$11.48B
Cash from Financing (TTM)
$2.92B
Net Change in Cash (TTM)
$633.10M
Filings
Filing Date
Thursday, May 1, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
0.61
7-Day Total Return
-9.42%
30-Day Total Return
-9.67%
60-Day Total Return
-11.63%
90-Day Total Return
-3.20%
Year to Date Total Return
-3.95%
1-Year Total Return
-0.89%
2-Year Total Return
73.80%
3-Year Total Return
162.06%
5-Year Total Return
402.29%
52-week Low
Apr 07, 2025 - $677.09
52-week High
Aug 22, 2024 - $972.53
Valuation
Market Cap
$678.30B - Mega Cap
Enterprise Value
$713.30B
Price/Sales (TTM)
13.89
Price/Book (Q)
45.42
Dividends and Shares
Shares Outstanding
900.60M
Dividend Per Share (Most Recent)
$1.50
Dividend Per Share (TTM)
$5.40
Corporate Info
Website
www.lilly.com
Phone Number
317 276 2000
Address
Lilly Corporate Center
Indianapolis, IN 46285
Country
United States
Year Founded
1876
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix... more
NYSE 05/13/2025 4:00PM Eastern Quotes delayed